KP
Kalvista Pharmaceuticals Inc
🇺🇸XNAS.KALVUnited StatesHealthcare
$27.00USDunchanged 0.00 (0%)OpenEnd of day3:32 PM
Price$27.000.00 (0%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US4834971032
- CUSIP
- 141384107
Company
- Employees
- 275
- Headquarters
- Framingham, United States
- Website
- https://www.kalvista.com
- CEO
- Mr. Benjamin L. Palleiko
Market
- Shares outstanding
- 53.2M
- Market cap
- $1.44B
Highlights
No high and low reported for today's session.
- Market cap
- $1.44B
- EPS LTM
- -$2.11calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -12.78calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $143.08M+100%up year on year
- Net income
- -$112.44M+38.71%up year on year
- Gross margin
- 92.24%
- Free cash flow
- -$38.51M+74.8%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.